Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Traws Pharma (TRAW)
NASDAQ:TRAW
Traws Pharma (TRAW) Stock Price & Analysis
1,798 Followers
TRAW Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.55 - $1.33
Previous Close$0.65
Volume27.98K
Average Volume (3M)129.53K
Market Cap
$16.45M
Enterprise Value$16.45M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-0.7
Beta1.43
Next Earnings
Aug 08, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.90
Shares Outstanding21,040,645
10 Day Avg. Volume53,967
30 Day Avg. Volume129,534
Standard Deviation0.37
R-Squared0.04
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)1.44
Price to Sales (P/S)60.52
Price to Cash Flow (P/CF)-1.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue72.78
Enterprise Value/Gross Profit72.78
Enterprise Value/Ebitda-0.79
Forecast
1Y Price Target
$7.00Price Target Upside964.80% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Traws Pharma News
Ownership Overview
61.63% Insiders
3.50% Mutual Funds
2.87% Other Institutional Investors
32.00% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TRAW FAQ
What was Traws Pharma’s price range in the past 12 months?
Traws Pharma lowest stock price was $0.55 and its highest was $1.33 in the past 12 months.
What is Traws Pharma’s market cap?
Currently, no data Available
When is Traws Pharma’s upcoming earnings report date?
Traws Pharma’s upcoming earnings report date is Aug 08, 2024 which is in 85 days.
How were Traws Pharma’s earnings last quarter?
Traws Pharma released its earnings results on May 13, 2024. The company reported -$0.28 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.28.
Is Traws Pharma overvalued?
According to Wall Street analysts Traws Pharma’s price is currently Undervalued.
Does Traws Pharma pay dividends?
Traws Pharma does not currently pay dividends.
What is Traws Pharma’s EPS estimate?
Traws Pharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Traws Pharma have?
Traws Pharma has 25,301,008 shares outstanding.
What happened to Traws Pharma’s price movement after its last earnings report?
Traws Pharma reported an EPS of -$0.28 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Traws Pharma?
Currently, no hedge funds are holding shares in TRAW
---
Traws Pharma Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$7.00 (964.80% Upside)
$7.00 (964.80% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 6.1%
Last 30 Days ▼ 6.1%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-48.00%
12-Months-Change
Fundamentals
Return on Equity
-97.22%
Trailing 12-Months
Asset Growth
-42.39%
Trailing 12-Months
Company Description
Traws Pharma
Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E. Premkumar Reddy on December 22, 1998 and is headquartered in Newtown, PA.
---
TRAW Earnings Call
Q3 2023
0:00 / 0:00
---
TRAW Stock 12 Month Forecast
Average Price Target
$7.00
▲(964.80% Upside)
Technical Analysis
Columbine Valley Resources
―
Cyclacel Pharmaceuticals
―
Cellectar Biosciences
―
Xenon
―
Best Analysts Covering TRAW
1 Year
1 Year Success Rate
2/16 ratings generated profit
1 Year Average Return
-40.04%
reiterated a buy rating 2 months ago
Copying Robert LeBoyer's trades and holding each position for 1 Year would result in 12.50% of your transactions generating a profit, with an average return of -40.04% per trade.
---